Skip to main content
. 2022 Dec 29;141(8):877–885. doi: 10.1182/blood.2022016202

Figure 2.

Figure 2.

Development and clinical testing of a bank of CD30.CAR-EBVSTs. Allogeneic CD30.CAR transduced EBVSTs (CD30.CAR-EBVSTs) will kill (1) recipient activated alloreactive T cells that upregulate CD30 upon activation and (2) CD30-expressing lymphoma cells. EBVSTs will not cause GVHD.